Predicted protein targets (top 17)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | LMNA | P02545 | 2/20 | 0.53 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.51 |
| ▸ | ALDH1A1 | P00352 | 3/20 | 0.43 |
| ▸ | TSHR | P16473 | 2/20 | 0.43 |
| ▸ | NR1I2 | O75469 | 1/20 | 0.40 |
| ▸ | POLB | P06746 | 1/20 | 0.39 |
| ▸ | CTSK | P43235 | 5/20 | 0.39 |
| ▸ | CTSL | P07711 | 2/20 | 0.39 |
| ▸ | CTSB | P07858 | 2/20 | 0.39 |
| ▸ | CTSH | P09668 | 2/20 | 0.39 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.38 |
| ▸ | MEN1 | O00255 | 1/20 | 0.38 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.38 |
| ▸ | CNR2 | P34972 | 1/20 | 0.37 |
| ▸ | AKR1C3 | P42330 | 1/20 | 0.36 |
| ▸ | ELANE | P08246 | 1/20 | 0.36 |
| ▸ | EGFR | P00533 | 1/20 | 0.35 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL11530703 | 0.79 | TSHR (0.45) | LMNATDP1ALDH1A1TSHRNR1I2 | |
| SCHEMBL11261129 | 0.76 | ALDH1A1 (0.55) | LMNATDP1ALDH1A1TSHRNR1I2 | |
| SCHEMBL11261126 | 0.76 | ALDH1A1 (0.55) | LMNATDP1ALDH1A1TSHRNR1I2 | |
| SCHEMBL9111048 | 0.72 | HDAC3 (0.51) | LMNATDP1ALDH1A1TSHRPOLB | |
| SCHEMBL19210261 | 0.72 | LMNA (0.46) | LMNATDP1ALDH1A1POLBMEN1 | |
| SCHEMBL229782 | 0.70 | LMNA (0.90) | LMNATDP1ALDH1A1TSHRNR1I2 | |
| SCHEMBL113478 | 0.70 | LMNA (0.90) | LMNATDP1ALDH1A1TSHRNR1I2 | |
| SCHEMBL230863 | 0.70 | LMNA (0.90) | LMNATDP1ALDH1A1TSHRNR1I2 | |
| SCHEMBL113319 | 0.69 | LMNA (1.00) | LMNATDP1ALDH1A1TSHRMEN1 | |
| SCHEMBL147065 | 0.69 | LMNA (1.00) | LMNATDP1ALDH1A1TSHRMEN1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 105 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-0562078-B1 | NON-MALODOROUS HAIR PERMING METHOD | OREAL (FR) | 1995-10-04 | — | — | EP | claimed |
| EP-0562078-A1 | NON-MALODOROUS HAIR PERMING METHOD. | OREAL (FR) | 1993-09-29 | — | — | EP | claimed |
| WO-1993005758-A1 | NON-MALODOROUS HAIR PERMING METHOD | L'OREAL (FR) | 1993-04-01 | — | — | WO | claimed |
| US-12617602-B2 | Aerosol dispenser and nozzle with reduced drip | THE PROCTER & GAMBLE COMPANY (US) | 2026-05-05 | — | — | US | disclosed |
| US-20260115124-A1 | FRESHENING COMPOSITION | PROCTER & GAMBLE (US) | 2026-04-30 | — | — | US | disclosed |
| US-20260115123-A1 | FRESHENING COMPOSITION | PROCTER & GAMBLE (US) | 2026-04-30 | — | — | US | disclosed |
| WO-2026090470-A1 | FRESHENING COMPOSITION | THE PROCTER & GAMBLE COMPANY (US) | 2026-04-30 | — | — | WO | disclosed |
| US-12606363-B2 | Aerosol dispenser and nozzle | THE PROCTER & GAMBLE COMPANY (US) | 2026-04-21 | — | — | US | disclosed |
| EP-3149143-B1 | USE OF POLYPEPTIDE | NOVOZYMES AS (DK) | 2025-08-06 | — | — | EP | disclosed |
| US-20250242366-A1 | POWERED SPRAY DISPENSER | PROCTER & GAMBLE COMPANY, THE | 2025-07-31 | — | — | US | disclosed |
| EP-4159283-B1 | GELS COMPRISING A HYDROPHOBIC MATERIAL | PROCTER & GAMBLE INT OPERATIONS SA (CH) | 2025-03-05 | — | — | EP | disclosed |
| EP-2512532-A1 | MALODOR CONTROL COMPOSITION HAVING AN ACID CATALYST AND METHODS THEREOF | The Procter & Gamble Company (US) | 2012-10-24 | — | — | EP | disclosed |
| EP-2512531-A1 | DISHWASHING DETERGENT COMPOSITION HAVING A MALODOR CONTROL COMPONENT AND METHODS OF CLEANING DISHWARE | The Procter & Gamble Company (US) | 2012-10-24 | — | — | EP | disclosed |
| EP-2512526-A1 | MALODOR CONTROL COMPOSITION HAVING A MIXTURE OF VOLATILE ALDEHYDES AND METHODS THEREOF | The Procter & Gamble Company (US) | 2012-10-24 | — | — | EP | disclosed |
| EP-2512530-A1 | LAUNDRY DETERGENT COMPOSITION HAVING A MALODOR CONTROL COMPONENT AND METHODS OF LAUNDERING FABRICS | The Procter & Gamble Company (US) | 2012-10-24 | — | — | EP | disclosed |
| WO-2012078208-A1 | MALODOR CONTROL COMPOSITIONS COMPRISING MALODOR CONTROL POLYMERS AND ACID CATALYSTS AND METHODS THEREOF | THE PROCTER & GAMBLE COMPANY (US) | 2012-06-14 | — | — | WO | disclosed |
| WO-2012078626-A2 | UNSCENTED AND LOW SCENTED MALODOR CONTROL COMPOSITIONS AND METHODS THEREOF | THE PROCTER & GAMBLE COMPANY (US) | 2012-06-14 | — | — | WO | disclosed |
| US-20110305659-A1 | FRESHENING COMPOSITIONS COMPRISING MALODOR BINDING POLYMERS AND MALODOR CONTROL COMPONENTS | THE PROCTER & GAMBLE COMPANY | 2011-12-15 | — | — | US | disclosed |
| WO-2010053891-A1 | MALODOR CONTROL SYSTEM | THE PROCTER & GAMBLE COMPANY (US) | 2010-05-14 | — | — | WO | disclosed |
| US-20100111889-A1 | Malodor Control System | PROCTER & GAMBLE COMPANY, THE | 2010-05-06 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (4 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-12606363-B2 | Aerosol dispenser and nozzle | DVL1, DVL3, EXOSC9 | LMNA 4186/4885TDP1 4876/4885ALDH1A1 1667/4885 |
| US-20260115124-A1 | FRESHENING COMPOSITION | SORD, ADH1C, HBB | LMNA 3207/4885TDP1 2274/4885ALDH1A1 2078/4885 |
| US-12617602-B2 | Aerosol dispenser and nozzle with reduced drip | EXOSC9, DVL1, DVL3 | LMNA 2515/4885TDP1 4789/4885ALDH1A1 1261/4885 |
| US-20260115123-A1 | FRESHENING COMPOSITION | SORD, LDHB, LCT | LMNA 2003/4885TDP1 2182/4885ALDH1A1 1051/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.